GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Clover Health Investments Corp (NAS:CLOV) » Definitions » EV-to-FCF

Clover Health Investments (Clover Health Investments) EV-to-FCF : -0.72 (As of Apr. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clover Health Investments EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Clover Health Investments's Enterprise Value is $84 Mil. Clover Health Investments's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-116 Mil. Therefore, Clover Health Investments's EV-to-FCF for today is -0.72.

The historical rank and industry rank for Clover Health Investments's EV-to-FCF or its related term are showing as below:

CLOV' s EV-to-FCF Range Over the Past 10 Years
Min: -54.33   Med: -2.1   Max: 3.25
Current: -0.72

During the past 5 years, the highest EV-to-FCF of Clover Health Investments was 3.25. The lowest was -54.33. And the median was -2.10.

CLOV's EV-to-FCF is ranked worse than
100% of 14 companies
in the Healthcare Plans industry
Industry Median: 14.995 vs CLOV: -0.72

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), Clover Health Investments's stock price is $0.67. Clover Health Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.440. Therefore, Clover Health Investments's PE Ratio for today is At Loss.


Clover Health Investments EV-to-FCF Historical Data

The historical data trend for Clover Health Investments's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Health Investments EV-to-FCF Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - -4.13 -0.40 -1.95

Clover Health Investments Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.40 0.02 1.30 -0.08 -1.95

Competitive Comparison of Clover Health Investments's EV-to-FCF

For the Healthcare Plans subindustry, Clover Health Investments's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clover Health Investments's EV-to-FCF Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's EV-to-FCF falls into.



Clover Health Investments EV-to-FCF Calculation

Clover Health Investments's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=83.918/-116.455
=-0.72

Clover Health Investments's current Enterprise Value is $84 Mil.
Clover Health Investments's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-116 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clover Health Investments  (NAS:CLOV) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Clover Health Investments's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.67/-0.440
=At Loss

Clover Health Investments's share price for today is $0.67.
Clover Health Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.440.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Clover Health Investments EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Clover Health Investments's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Clover Health Investments (Clover Health Investments) Business Description

Traded in Other Exchanges
Address
3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.
Executives
Karen Soares officer: General Counsel & Secretary 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Clover Health Investments, Corp. /de officer: Chief Technology Officer 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Anna U Loengard director C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Andrew Toy director, officer: Chief Executive Officer C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Scott J. Leffler officer: Chief Financial Officer C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Brady Patrick Priest officer: CEO of Home Care C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067
Demetrios L. Kouzoukas director C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067
Aric R Sharp officer: CEO of Value-Based Care C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Wai Conrad officer: Chief Technology Officer 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Joseph Richards Martin officer: General Counsel C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219
Vivek Garipalli director, 10 percent owner, officer: Executive Chairperson C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Carladenise Armbrister Edwards director C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Chelsea Clinton director C/O IAC 555 W 18TH STREET, NEW YORK NY 10011
Jamie L. Reynoso officer: CEO of Medicare Advantage C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Chamath Palihapitiya 10 percent owner, other: See Remarks THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025